SMPL heads into its next earnings print with short sellers at their most aggressive in months, analyst conviction evaporating, and options traders positioned firmly for further pain.
The shift in short positioning is the defining feature of this setup. Short interest has nearly doubled since late April — from roughly 4% of the free float to 7.8% today. The move was not gradual. Bears added materially around the time of the Q2 fiscal results on April 9, then paused briefly, before ratcheting higher again through May. Over the past month alone, estimated short interest has risen more than 84%. Days to cover via the most recent FINRA settlement are just under three days, so the position is large relative to liquidity but not extreme. Crucially, the borrow market remains wide open: availability runs above 1,300% — meaning roughly thirteen shares are available to lend for every one already borrowed — and the cost to borrow is barely 0.47%, well below anything that would constrain incremental shorting. There is no mechanical squeeze pressure here. Bears can add at minimal cost.
Options positioning has shifted with equal force. The put/call ratio has more than doubled from where it traded in late April. It hovered around 0.29-0.30 for most of May before jumping sharply to around 0.70 in the week of May 20, where it has held ever since. At 0.71, PCR is now more than one standard deviation above its 20-day average and near the highest level of the past year. That is not a subtle hedge — it reflects deliberate demand for downside protection into the June 30 earnings date.
The Street has turned more negative, and quickly. Bernstein this morning downgraded the stock to Market Perform from Outperform, cutting its target to $12 from $17 — a direct reversal of its bullish stance. UBS trimmed its target to $12 from $13 yesterday while holding Neutral. Both moves reflect the same read: the turnaround narrative that once underpinned the bull case has cracked. Multiple other analysts cut targets sharply after the April 9 earnings disaster — Morgan Stanley lowered to $14 from $24, TD Cowen to $13 from $20, Stephens downgraded to Equal-Weight while slashing to $14 from $24. The consensus is now eight holds to four buys, with a mean target of around $17, though many of those targets were set before the April collapse and likely lag the more recent cuts. The current stock price of $11.81 reflects a market that has moved ahead of the consensus. (One legacy target of $39 on the sheet is clearly outdated given the company's trajectory and current price level — it should be treated as stale.) EV/EBITDA at 5.7x and a P/E near 7x suggest the market is pricing in continued deterioration rather than recovery. The bear case centres on weak consumption for Atkins and OWYN, distribution losses, tariff-driven cost inflation, and a balance sheet with elevated leverage.
The insider picture offers the one divergent signal. Chairman James Kilts put nearly $1 million to work on April 23, buying 80,000 shares at around $12.39. A director added a further 10,000 shares in mid-May at $11.78. In aggregate, insiders are net buyers of roughly $1.2 million over the past 90 days. Those are not token buys — Kilts has been a consistent accumulator and his purchase arrived less than two weeks after the stock's worst single-day move in years. Whether that conviction is vindicated depends entirely on whether the turnaround targets — 40% gross margins, 20% EBITDA margins — are still credible with the current cost structure.
The April 9 print is a reference point that will dominate sentiment into June 30. SMPL fell 27.5% that day and was still down nearly 20% five sessions later. That is the scale of the de-rating that followed the last miss. The stock has partially stabilised — up 3.6% this week, though still down 11% over the past month — but the short build and options shift suggest the market is not treating the current price as a floor. What to watch on June 30 is whether the company can demonstrate any traction on gross margin recovery and provide a credible update on OWYN distribution; progress there would be the clearest signal that the Kilts-led accumulation has commercial backing behind it.
See the live data behind this article on ORTEX.
Open SMPL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
